Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

What should work, may not.

Publication ,  Other
Kirk, AD
Published in: Am J Transplant
March 2010

When new agents such as bortezomib appear, it is important to maintain scientific rigor regarding off-label use of medications.

Duke Scholars

Published In

Am J Transplant

DOI

EISSN

1600-6143

Publication Date

March 2010

Volume

10

Issue

3

Start / End Page

447 / 448

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Surgery
  • Research Design
  • Pyrazines
  • Organ Transplantation
  • Off-Label Use
  • Immunosuppressive Agents
  • Humans
  • Drug Prescriptions
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kirk, A. D. (2010). What should work, may not. Am J Transplant. United States. https://doi.org/10.1111/j.1600-6143.2010.03025.x
Kirk, A. D. “What should work, may not.Am J Transplant, March 2010. https://doi.org/10.1111/j.1600-6143.2010.03025.x.
Kirk AD. What should work, may not. Vol. 10, Am J Transplant. 2010. p. 447–8.
Kirk, A. D. “What should work, may not.Am J Transplant, vol. 10, no. 3, Mar. 2010, pp. 447–48. Pubmed, doi:10.1111/j.1600-6143.2010.03025.x.
Kirk AD. What should work, may not. Am J Transplant. 2010. p. 447–448.
Journal cover image

Published In

Am J Transplant

DOI

EISSN

1600-6143

Publication Date

March 2010

Volume

10

Issue

3

Start / End Page

447 / 448

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Surgery
  • Research Design
  • Pyrazines
  • Organ Transplantation
  • Off-Label Use
  • Immunosuppressive Agents
  • Humans
  • Drug Prescriptions